Results 151 to 160 of about 64,413 (204)

Inflammation and Cancer: Molecular Mechanisms and Therapeutic Targets

open access: yesMedComm, Volume 7, Issue 2, February 2026.
Chronic inflammation fuels tumorigenesis via “internal drivers” and “external attractions.” Targeting these core mechanisms with combined therapies/novel deliveries enables precise, potent anti‐inflammatory–antitumor treatment. ABSTRACT Inflammation is a core pathological factor regulating tumor initiation, progression, and therapeutic resistance, and ...
Xiaodie Liu   +4 more
wiley   +1 more source

Study of the cell biological role of Lowe Syndrome protein OCRL1 [PDF]

open access: yes, 2009
Oculocerebrorenal syndrome of Lowe (OCRL) is caused by mutations in a phosphatidylinositol 5-phosphatase, OCRL1, and is believed to lead to an elevation of its preferred substrate, PI(4,5)P2.
Grieve, A.G.
core  

A novel homeostatic mechanism tunes PI(4,5)P2-dependent signaling at the plasma membrane.

open access: yesJ Cell Sci, 2023
Wills RC   +5 more
europepmc   +1 more source

Phosphatidylinositides regulate the cell plate morphology transition during cytokinesis in Arabidopsis

open access: yesNature Communications
In plants, the developing cell plate which is characterized by a series of anionic lipids, undergoes dramatic morphological change for successful cytokinesis.
Yu Luo   +3 more
doaj   +1 more source

Rezeptorinduzierte PI(4,5)P2-Dynamik in hippocampalen CA1-Pyramidenneuronen

open access: yes, 2014
Das Plasmamembranlipid Phosphatidylinositol(4,5)biphosphat (PIP2) ist an der Regulation einer Vielzahl zellularer Prozesse beteiligt. Die Dynamik der PIP2-Konzentration in lebenden Zellen in ihrer nativen Umgebung ist bislang allerdings weitgehend unerforscht.
openaire   +2 more sources

Noncanonical PI(4,5)P2 coordinates lysosome positioning through cholesterol trafficking

open access: yes
AbstractIn p53-deficient cancers, targeting cholesterol metabolism has emerged as a promising therapeutic approach, given that p53 loss dysregulates sterol regulatory element-binding protein 2 (SREBP-2) pathways, thereby enhancing cholesterol biosynthesis. While cholesterol synthesis inhibitors such as statins have shown initial success, their efficacy
Ryan M. Loughran   +8 more
openaire   +1 more source

A conserved PI(4,5)P2-binding domain is critical for immune regulatory function of DOCK8. [PDF]

open access: yesLife Sci Alliance, 2021
Sakurai T   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy